Cynthia Sung
age ~65
from Silver Spring, MD
- Also known as:
-
- Sung Cynthia
- Ung Cs
- Phone and address:
-
9028 Fairview Rd, Silver Spring, MD 20910
(240)7057071
Cynthia Sung Phones & Addresses
- 9028 Fairview Rd, Silver Spring, MD 20910 • (240)7057071
- 9503 Thornhill Rd, Silver Spring, MD 20901 • (301)5872509
- Seattle, WA
- 454 Honering Trl, Annapolis, MD 21401 • (410)8493288
- 18 Stapleton Ct, Middletown, NY 10940
- Bethesda, MD
- Cambridge, MA
Resumes
Research Program Manager, Translational Sciences, Global Health
view sourceLocation:
Seattle, WA
Industry:
Non-Profit Organization Management
Work:
Bill & Melinda Gates Medical Research Institute
Research Program Manager, Translational Sciences, Global Health
Rainbow Pharma Consulting Pte Jan 2006 - Jul 2019
President
Duke-Nus Graduate Medical School Jan 2006 - Jul 2019
Adjunct Associate Professor
Duke-Nus Graduate Medical School 2010 - 2016
Adjunct Faculty, Emerging Infectious Disease Program
Health Sciences Authority 2010 - 2016
Visiting Regulatory Consultant
Research Program Manager, Translational Sciences, Global Health
Rainbow Pharma Consulting Pte Jan 2006 - Jul 2019
President
Duke-Nus Graduate Medical School Jan 2006 - Jul 2019
Adjunct Associate Professor
Duke-Nus Graduate Medical School 2010 - 2016
Adjunct Faculty, Emerging Infectious Disease Program
Health Sciences Authority 2010 - 2016
Visiting Regulatory Consultant
Education:
Massachusetts Institute of Technology 1982 - 1988
Doctorates, Master of Education, Masters, Doctor of Philosophy, Engineering, Physics Yale University 1976 - 1980
Bachelors, Bachelor of Science, Chemical Engineering
Doctorates, Master of Education, Masters, Doctor of Philosophy, Engineering, Physics Yale University 1976 - 1980
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Clinical Development
Drug Development
Clinical Pharmacology
Infectious Diseases
Drug Discovery
Vaccines
Biotechnology
Molecular Biology
Clinical Trials
Lifesciences
Research
Clinical Research
Life Sciences
Pharmaceutical Industry
Biopharmaceuticals
Cell Culture
Oncology
Technology Transfer
Biochemistry
Fda
Protein Chemistry
Drug Development
Clinical Pharmacology
Infectious Diseases
Drug Discovery
Vaccines
Biotechnology
Molecular Biology
Clinical Trials
Lifesciences
Research
Clinical Research
Life Sciences
Pharmaceutical Industry
Biopharmaceuticals
Cell Culture
Oncology
Technology Transfer
Biochemistry
Fda
Protein Chemistry
Interests:
Education
Languages:
Mandarin
French
French
Cynthia Sung
view sourceMedicine Doctors
Cynthia J. Sung
view sourceSpecialties:
Psychiatry
Work:
Psychiatry South
3000 Southlake Park STE 100, Birmingham, AL 35244
(205)9870724 (phone), (205)9870725 (fax)
3000 Southlake Park STE 100, Birmingham, AL 35244
(205)9870724 (phone), (205)9870725 (fax)
Education:
Medical School
University of North Texas College of Osteopathic Medicine
Graduated: 2007
University of North Texas College of Osteopathic Medicine
Graduated: 2007
Procedures:
Psychiatric Diagnosis or Evaluation
Psychiatric Therapeutic Procedures
Psychiatric Therapeutic Procedures
Conditions:
Anxiety Dissociative and Somatoform Disorders
Anxiety Phobic Disorders
Attention Deficit Disorder (ADD)
Depressive Disorders
Autism
Anxiety Phobic Disorders
Attention Deficit Disorder (ADD)
Depressive Disorders
Autism
Languages:
English
Description:
Dr. Sung graduated from the University of North Texas College of Osteopathic Medicine in 2007. She works in Birmingham, AL and specializes in Psychiatry.
Us Patents
-
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
view source -
US Patent:6713081, Mar 30, 2004
-
Filed:Mar 15, 2001
-
Appl. No.:09/808149
-
Inventors:Michael R. Robinson - Kensington MD
Karl G. Csaky - Kensington MD
Peng Yuan - Rockville MD
Cynthia Sung - Silver Spring MD
Robert B. Nussenblatt - Bethesda MD
Janine A. Smith - Potomac MD -
Assignee:The United States of America as represented by the Department of Health and Human Services - Washington DC
-
International Classification:A61F 200
-
US Classification:424427, 424422, 424423, 424424, 424425, 424426, 424428, 424484, 424485, 424486, 424487, 424488, 424 7804
-
Abstract:Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described. Implants suitable for subconjunctival placement are described. Implants suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices that are presented herein.
-
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
view source -
US Patent:7658364, Feb 9, 2010
-
Filed:Mar 14, 2002
-
Appl. No.:10/471468
-
Inventors:Michael R. Robinson - Kensington MD, US
Karl G. Csaky - Kensington MD, US
Robert B. Nussenblatt - Bethesda MD, US
Janine A. Smith - Potomac MD, US
Peng Yuan - Rockville MD, US
Cynthia Sung - Silver Spring MD, US
Matthew P. Fronheiser - Durham NC, US
Hyuncheol Kim - North Bethesda MD, US -
Assignee:The United States of America as represented by the Department of Health and Human Services - Washington DC
-
International Classification:B29D 11/00
A61F 2/00 -
US Classification:249117, 2491141, 249144, 249175, 249177, 425808, 424427
-
Abstract:Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
-
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
view source -
US Patent:20070190111, Aug 16, 2007
-
Filed:Apr 24, 2007
-
Appl. No.:11/739540
-
Inventors:Michael Robinson - Irvine CA, US
Karl Csaky - Kensington MD, US
Robert Nussenblatt - Bethesda MD, US
Janine Smith - Potomac MD, US
Peng Yuan - Rockville MD, US
Cynthia Sung - Silver Spring MD, US
Matthew Fronheiser - Durham NC, US
Hyuncheol Kim - North Bethesda MD, US -
Assignee:Govemment of the U.S.A, represented by the Secretary, Department. of Health and Human - Rockville MD
-
International Classification:A61F 2/02
-
US Classification:424427000
-
Abstract:Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
-
Ocular Therapeutic Agent Delivery Devices And Methdos For Making And Using Such Devices
view source -
US Patent:20100272777, Oct 28, 2010
-
Filed:Dec 28, 2009
-
Appl. No.:12/647980
-
Inventors:Michael R. Robinson - Kensington MD, US
Karl G. Csaky - Kensington MD, US
Robert B. Nussenblatt - Bethesda MD, US
Janine A. Smith - Potomac MD, US
Peng Yuan - Rockville MD, US
Cynthia Sung - Silver Spring MD, US
Matthew P. Fronheiser - Washington DC, US
Hyuncheol Kim - Greenbelt MD, US -
Assignee:Department of Health - Rockville MD
-
International Classification:A61K 9/00
B05D 3/00
A61K 38/13
A61P 27/02 -
US Classification:424423, 424427, 427 214, 514 205
-
Abstract:Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
-
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
view source -
US Patent:20160158146, Jun 9, 2016
-
Filed:Feb 17, 2016
-
Appl. No.:15/045752
-
Inventors:- Rockville MD, US
Karl G. Csaky - Kensington MD, US
Robert B. Nussenblatt - Bethesda MD, US
Janine A. Smith - Potomac MD, US
Peng Yuan - Rockville MD, US
Cynthia Sung - Silver Spring MD, US
Matthew P. Fronheiser - Washington DC, US
Hyuncheol Kim - North Bethesda MD, US -
International Classification:A61K 9/00
B29D 11/02
A61K 31/565
A61K 31/58
A61K 9/50
A61K 38/13 -
Abstract:Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
Googleplus
Cynthia Sung
About:
我是....恩...
Tagline:
多________沒事 沒事多________
Classmates
Cynthia Sung
view sourceSchools:
Hawthorn School Vernon Hills IL 1985-1994
Community:
Judi Foley, Aina Wirthlin, Barb Burdock, Chris Caproon, Susan Giffin
Youtube
Get Report for Cynthia Sung from Silver Spring, MD, age ~65